Ardent Health (ARDT) closed at $11.95 on October 16, 2026, down 2.0% from the previous close, on volume of 633,977 shares (30-day average 470,863).
Data as of October 16, 2026.
16-Oct-2026
Ardent Health Announces Third Quarter 2026 Results Conference Call and Webcast Date
Business Wire (Thu, 15-Oct 4:15 PM ET)
Business Wire (Tue, 29-Sep 4:15 PM ET)
Business Wire (Tue, 15-Sep 8:00 AM ET)
Business Wire (Mon, 14-Sep 9:25 AM ET)
Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine
Business Wire (Wed, 2-Sep 8:00 AM ET)
Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
Business Wire (Thu, 27-Aug 8:00 AM ET)
Ardent Health Reports Second Quarter 2026 Results
Business Wire (Tue, 4-Aug 4:15 PM ET)
Ardent Health surpasses 1 million patient encounters supported by ambient AI
Business Wire (Thu, 23-Jul 8:00 AM ET)
Business Wire (Thu, 23-Jul 7:00 AM ET)
Ardent Health Draws Investor Attention Ahead of Key Goldman Sachs Healthcare Conference
Market Chameleon (Thu, 4-Jun 7:09 AM ET)
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S and operating in eight growing mid-sized urban markets across six states Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The main focus on people and investments in services and technologies.
Ardent Health trades on the NYSE stock market under the symbol ARDT.
As of October 16, 2026, ARDT stock price declined to $11.95 with 633,977 million shares trading.
ARDT has a beta of 0.66, meaning it tends to be less sensitive to market movements. ARDT has a correlation of 0.02 to the broad based SPY ETF.
ARDT has a market cap of $1.69 billion. This is considered a Small Cap stock.
Last quarter Ardent Health reported $2 billion in Revenue and $.12 earnings per share. This fell short of revenue expectation by $-8 million and missed earnings estimates by -$.10.
The top ETF exchange traded funds that ARDT belongs to (by Net Assets): AVUV, VTI, IWM, BSVO, FYX.
ARDT has underperformed the market in the last year with a return of -18.1%, while SPY returned +16.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ARDT shares. However, ARDT has outperformed the market in the last 3 month and 2 week periods, returning +17.2% and +15.6%, while SPY returned +1.9% and -0.8%, respectively. This indicates ARDT has been having a stronger performance recently.
ARDT support price is $11.89 and resistance is $12.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARDT shares will trade within this expected range on the day.